Database of patients with colorectal cancer at Institut Paoli Calmettes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves the creation of a comprehensive database of patients diagnosed with colorectal cancer at the Institut Paoli Calmettes. The database will collect various clinical data to better understand the disease and its treatment outcomes. By compiling this information, researchers aim to facilitate future studies and improve patient care. The study does not involve any specific interventions or treatments, focusing solely on data collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a colorectal cancer diagnosis

Exclusion Criteria:

* Non applicable

Where it's running

• Institut Paoli Calmettes
  Marseille, Bouches du Rhone, France Recruiting

Study contacts

• Study coordinator: Dominique Genre, MD
• Email: drci.up@ipc.unicancer.fr
• Phone: 0033491223778

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers in Colorectal Cancer: A Longitudinal Study Using Biobanks and Blood Samples

  This study tests whether clinical and molecular biomarkers from tumor tissue and blood can predict treatment response, recurrence, and survival in adults with colorectal cancer undergoing surgery.

  Recruiting at 2 sites Vorarlberg Institute for Vascular Investigation and Treatment · Bregenz, Vorarlberg and 3 other locations · NCT07913802

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer

  A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.

  Recruiting Masaryk Memorial Cancer Institute · Brno, Czech Republic · NCT07895459

• Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery

  Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07830576

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• AI-powered stool image analysis to see if it matches FIT results in colorectal cancer screening

  We’re testing whether AI-derived features from stool images can align with FIT results in adults being screened or evaluated for colorectal neoplasia.

  Recruiting Servicio de Salud Metropolitano Sur Oriente · Santiago, Santiago Metropolitan · NCT07740122

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.